70861 - Instruments for the Fragility Syndrome Screening

Academic Year 2026/2027

  • Docente: Paola Forti
  • Credits: 1
  • SSD: MEDS-05/A
  • Language: Italian
  • Teaching Mode: In-person learning (entirely or partially)
  • Campus: Bologna
  • Corso: Single cycle degree programme (LMCU) in Medicine and Surgery (cod. 8415)

Learning outcomes

At the end of the course, the student will know

- basic notions about frailty and its clinical meaning

- the relationship between frailty and polypharmacy

- how to use a frailty screening tool in different settings

- how to identify common interactions between frailty and drugs

- basic principles for drug prescription in older patients

Course contents

Common geriatric screening tools for cognitive and functional status

Frailty

Frailty tools: physical phenotype and cumulative approach

DIfferent tools for different settings?

Performance tests

Readings/Bibliography

Slides of the lesson

Teaching methods

Frontal lessons

Assessment methods

Questionnaire at the end of each lesson

 

Students with Specific Learning Disorders (SLD) or with temporary or permanent disabilities: they are strongly advised to contact the University office in charge well in advance (Ufficio Studenti con Disabilità e DSA [https://site.unibo.it/studenti-con-disabilita-e-dsa/it] ). The office will evaluate each case and may propose appropriate accommodations for the students concerned. Any proposed adaptation must, however, be submitted to the course instructor for approval at least 15 days in advance; the instructor will assess its suitability in relation to the learning objectives of the course.

Regarding the assessment of learning, the use of AI tools is strictly prohibited. Any use of such tools constitutes a violation of academic integrity.

Teaching tools

Slides of the lession, clinical cases

Office hours

See the website of Paola Forti

SDGs

Good health and well-being

This teaching activity contributes to the achievement of the Sustainable Development Goals of the UN 2030 Agenda.